BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29602736)

  • 1. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
    Sebastianelli A; Gacci M
    Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
    BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
    Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
    Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
    Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
    Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile Dysfunction and Lower Urinary Tract Symptoms.
    De Nunzio C; Roehrborn CG; Andersson KE; McVary KT
    Eur Urol Focus; 2017 Oct; 3(4-5):352-363. PubMed ID: 29191671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S; Tang J; Shao S; Yan Y
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate.
    De Nunzio C; Tema G; Lombardo R; Cicione A; Nacchia A; D'Annunzio S; Sarchi L; Proietti F; Brassetti A; Tubaro A
    Neurourol Urodyn; 2019 Aug; 38(6):1692-1699. PubMed ID: 31107572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
    Park SG; Yeo JK; Cho DY; Park MG
    Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
    BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between lower urinary tract symptoms and metabolic syndrome in a Chinese male population.
    Pan JG; Liu M; Zhou X
    J Endocrinol Invest; 2014 Apr; 37(4):339-44. PubMed ID: 24682909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.
    De Nunzio C; Truscelli G; Presicce F; Bellangino M; Gacci M; Gaudio C; Tubaro A
    Minerva Urol Nefrol; 2018 Jun; 70(3):340-346. PubMed ID: 29478309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
    Vignozzi L; Gacci M; Maggi M
    Nat Rev Urol; 2016 Feb; 13(2):108-19. PubMed ID: 26754190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.